SCHEMBL17197050

SCHEMBL17197050

Cc1ccc(OCCN2CCC3(CC2)OCCO3)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 3/20 0.60
▸ GRIN2D O15399 1/20 0.55
▸ GRIN3B O60391 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ GRIN1 Q05586 1/20 0.55
▸ GRIN2A Q12879 1/20 0.55
▸ GRIN2B Q13224 1/20 0.55
▸ GRIN2C Q14957 1/20 0.55
▸ GRIN3A Q8TCU5 1/20 0.55
▸ ESR1 P03372 1/20 0.48
▸ ESR2 Q92731 1/20 0.48
▸ ADORA2A P29274 1/20 0.48
▸ KCNA5 P22460 2/20 0.48
▸ MAPK1 P28482 2/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ CHRM2 P08172 1/20 0.48
▸ CHRM1 P11229 1/20 0.48
▸ HTR2A P28223 1/20 0.48
▸ SCN1A P35498 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9199004 0.86 HRH3 (0.60) HRH3ESR1ESR2ALDH1A1HTR2A
SCHEMBL7132136 0.81 LTA4H (0.70) HRH3PSMB1PSMB5PSMB2
SCHEMBL82404 0.81 HRH3 (0.59) HRH3GRIN2DGRIN3BMAPTGRIN1
SCHEMBL82383 0.80 ALDH1A1 (0.67) HRH3MAPK1ALDH1A1CYP1A2CHRM2
SCHEMBL25462936 0.79 MAPT (0.64) HRH3GRIN2DGRIN3BMAPTGRIN1
SCHEMBL82436 0.79 GRIN2D (0.57) HRH3GRIN2DGRIN3BMAPTGRIN1
SCHEMBL11753349 0.79 MEN1 (0.59) HRH3ALDH1A1HTR2AKDM4E
SCHEMBL15834053 0.78 HRH3 (0.66) HRH3KDM4EPSMB1PSMB5PSMB2
SCHEMBL8337754 0.78 HRH3 (0.70) HRH3ALDH1A1KDM4EPSMB1PSMB5
SCHEMBL10191921 0.77 LTA4H (0.65) HRH3KCNA5ALDH1A1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015160192-A1 PHARMACEUTICAL COMPOSITION FOR TREATING AND PREVENTING LEUKEMIA, CONTAINING THIENOPYRIMIDINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF 연세대학교 산학협력단 2015-10-22 — — WO disclosed
Send feedback